Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-01 @ 8:20 PM
Study NCT ID:
NCT02054351
Status:
COMPLETED
Last Update Posted:
2024-11-21
First Post:
2014-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
Sponsor:
Ganymed Pharmaceuticals GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-29
First Submit QC Date:
None
Study First Post Date:
2014-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-11-21
Last Update Post Date Type:
ACTUAL